K Number
K203179
Date Cleared
2020-11-20

(25 days)

Product Code
Regulation Number
870.1340
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Fortress Introducer Sheath System is intended to provide access and to facilitate percutaneous introduction of guide wires, catheters and other devices into the femoral, popliteal arteries while maintaining hemostasis during diagnostic and interventional procedures.

Device Description

The Fortress Introducer Sheath System consists of an introducer sheath with hemostasis valve and side port, as well as a dilator with a tapered tip and luer lock at the proximal end. The main introducer sheath tubing is connected at the proximal end to a hemostasis valve with side port tubing that is connected to a plastic color coded 3-way stopcock valve. The side port is used for flushing the introducer sheath. The introducer sheath is introduced into the vascular system with the aid of the dilator. The hemostasis valve at the proximal end of the introducer sheath conforms and seals around guide wires and catheters to reduce blood leakage from the introducer sheath. A radiopaque marker helps identify the distal end of the introducer sheath. The introducer sheath has a hydrophobic silicone coating on the outer surface of the distal 30cm portion.

AI/ML Overview

The provided text describes the regulatory clearance for the Fortress Introducer Sheath System (7F and 8F sizes) and does not contain information about an AI/ML powered medical device. Therefore, a table of acceptance criteria and reported device performance related to AI/ML capabilities, or details about a study evaluating such a device, cannot be extracted from this document.

The document discusses the substantial equivalence of the Fortress Introducer Sheath System (7F and 8F) to a predicate device (6F Fortress Introducer Sheath System, K153197). The performance data presented are for non-clinical tests related to the mechanical properties, biocompatibility, sterilization, and shelf-life of the physical device.

Here's an analysis of what can be extracted from the document, recognizing that it doesn't pertain to an AI/ML device:

1. Table of Acceptance Criteria and Reported Device Performance (as non-AI/ML)

Since this is a non-AI/ML device, "acceptance criteria" here refers to specific tests and relevant standards the device must meet. The "reported device performance" is that the device met these criteria, demonstrating substantial equivalence to the predicate.

Verification / Validation ActivityTest TypeApplicable Standard(s)Device Performance
Sheath/dilator fit testMechanical/VisualInternal requirementMet Criteria
Sheath pull out testMechanical/VisualASTM F2394, ISO 10555-1:2013Met Criteria
Sheath kink resistance testMechanicalEN 13868:2002Met Criteria
Sheath force at break testMechanicalISO 10555-1:2013Met Criteria
Sheath creep to break testMechanicalISO 10555-1:2013Met Criteria
Dilator hub bond strengthMechanicalISO 10555-1:2013Met Criteria
Sheath system insertion forceMechanicalInternal requirementMet Criteria
Usability evaluationUsability StudyIEC 62366-1:2015Met Criteria
Simulated use testMechanical/VisualASTM F2394Met Criteria
Accelerated age test (3 years)Mechanical/External LaboratoryASTM F1980-16, Various per performed testsMet Criteria
Biocompatibility testing (Cytotoxicity, Biological Risk Assessment)External Laboratory/Documented assessmentISO 10993-1:2009, ISO 10993-4:2017, ISO 10993-5:2009, ISO 10993-10:2010, ISO 10993-11:2017, ISO 10993-12:2012, ISO 14971:2019, FDA Guidance Use of International Standard ISO 10993-1Met Criteria
Sterilization adoptionDocumented assessment/External laboratory testingISO 10993-7:2008, ISO 11737-1:2018, ISO 11135:2014, ISO 10993-1:2018Met Criteria

2. Sample size used for the test set and the data provenance:

  • Test Set Sample Size: Not explicitly stated for each test, but it is implied that sufficient samples were tested to meet the requirements of the standards listed. These are physical device tests, not data-driven AI/ML tests.
  • Data Provenance: The tests are non-clinical (laboratory-based) and conducted to international and internal standards. Provenance is therefore the testing conducted by the manufacturer and/or external laboratories. The country of origin for the device manufacturer is Germany.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

  • This information is not applicable as the document describes physical device testing, not an AI/ML product requiring expert ground truth for image or data analysis. Usability evaluation (IEC 62366-1:2015) would involve human users, but the number and qualifications of those users are not specified, nor are they "experts establishing ground truth" in the AI/ML sense.

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

  • This is not applicable as the document describes physical device testing. The results are determined by compliance with specified test methods and acceptance criteria rather than expert adjudication.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

  • This is not applicable as the device is a physical medical introducer sheath system, not an AI/ML product intended to assist human readers.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

  • This is not applicable as the device is a physical medical introducer sheath system, not an AI/ML algorithm.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

  • This is not applicable as the document describes physical device testing. The "ground truth" or reference for evaluating performance against is defined by the technical specifications outlined in the referenced international standards and internal requirements.

8. The sample size for the training set:

  • This is not applicable as the device is a physical medical introducer sheath system and does not involve AI/ML requiring a training set.

9. How the ground truth for the training set was established:

  • This is not applicable as the device is a physical medical introducer sheath system and does not involve AI/ML requiring a training set.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, with the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

November 20, 2020

Contract Medical International, GmbH Marketa Shanelova Regulatory Manager Lauensteiner Strasse 37 Dresden, Saxony 01277 Germany

Re: K203179

Trade/Device Name: Fortress Introducer Sheath System Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter Introducer Regulatory Class: Class II Product Code: DYB, DRE Dated: October 23, 2020 Received: October 26, 2020

Dear Marketa Shanelova:

We have reviewed vour Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and

{1}------------------------------------------------

regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4. Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reporting-mdr-howreport-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) CDRH and -Learn (https://www.fda.gov/training-and-continuing-education/odrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

for

Misti Malone Assistant Director DHT2C: Division of Coronary and Peripheral Intervention Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K203179

Device Name Fortress Introducer Sheath System

Indications for Use (Describe)

The Fortress Introducer Sheath System is intended to provide access and to facilitate percutaneous introduction of guide wires, catheters and other devices into the femoral, popliteal arteries while maintaining hemostasis during diagnostic and interventional procedures.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) SUMMARY 2

2.1 Submitter

Submitter:Contract Medical GmbH
Lauensteiner Strasse 37
01277 Dresden
Germany
Contact Person:Marketa Shanelova, Regulatory Manager
Phone:+420 494 949 586
Email:marketa.shanelova@heraeus.com
Date Summary Prepared:23 October 2020

2.2 Device Device Trade Name: Fortress Introducer Sheath System Device Common Name: Introducer Sheath Classification Name: Introducer Catheter, and Dilator, Vessel, For Percutaneous Catheterization Device Class: . Product Code: DYB, and DRE

2.3 Predicate Device

The predicate device is the 6F size of the Fortress Introducer Sheath System (K153197)

2.4 Device Description

The Fortress Introducer Sheath System consists of an introducer sheath with hemostasis valve and side port, as well as a dilator with a tapered tip and luer lock at the proximal end. The main introducer sheath tubing is connected at the proximal end to a hemostasis valve with side port tubing that is connected to a plastic color coded 3-way stopcock valve. The side port is used for flushing the introducer sheath. The introducer sheath is introduced into the vascular system with the aid of the dilator. The hemostasis valve at the proximal end of the introducer sheath conforms and seals around guide wires and catheters to reduce blood leakage from the introducer sheath. A radiopaque marker helps identify the distal end of the introducer sheath. The introducer sheath has a hydrophobic silicone coating on the outer surface of the distal 30cm portion.

The System consists of the following components:

  • A One Introducer Sheath (a) with hemostasis valve (b)
  • A One dilator (c)

(a) Shaft. The coil reinforced multi-layer polymer shaft contains a tapered tip at the distal end. A continuous inner PTFE tube forms the core of the shaft and provides a circular working lumen through which devices can be passed. A single, full length polyether (Pebax) tube creates the outer cover of the shaft. A stainless-steel flat wire coil is fused between the two polymer tubes along the entire

{4}------------------------------------------------

length of the shaft. Hydrophobic coating is applied along the distal 30cm of the outer layer for increased lubricity in this area. A radiopaque marker made of platinum iridium is embedded at the distal end of the shaft. At the proximal end of the shaft, a female, winged luer hub is over-molded onto the shaft to support handling and to provide for the connection for the hemostasis valve. The hub is color coded to match the French size of the device.

(b) Hemostasis valve. A removable hemostasis valve is thread onto the luer hub at the proximal end of the shaft. Inside the valve housing, a lubricated, silicone slit disc provides a seal around devices passed through the sheath, thereby preventing blood leakage through the valve. Just distal of the valve, the valve housing is connected to a side port tube leading to three-way stopcock valve. The side port is used for flushing the introducer sheath. At the proximal end of the valve housing, the color-coded housing cap provides a snap fit connection to the hub of the dilator.

(c) Dilator. The dilator made of Pebax contains a full length round lumen to allow placement over a guide wire. The distal end of the dilator is configured as a tapered tip that extends 35+/-7mm beyond the end of the sheath when the dilator is fully inserted through the sheath. An integral, color coded luer hub that is over-molded onto the proximal end of the dilator supports handling of the dilator and provides a snap fit connection to the valve housing cap at the proximal end of the sheath introducer.

The shaft and hemostasis valve are pre-assembled and packaged together with a dilator. Each shaft and each dilator are placed in a separate protection tube, the protection tubes are clamped together with clips. Products are sealed inside an inner and outer medical grade Tyvek pouch on which a product label is placed. Devices are packaged in labeled packers containing five units and one Instruction for Use (IFU) booklet.

The Fortress Introducer Sheath System is a sterile, disposable device. It is a prescription medical device that is used only in healthcare facilities or hospitals. The device is placed in patients for up to 24 hours.

Devices are sterilized using ethylene oxide (maximum levels of remaining tested sterilant residuals of EO < 2.9mg/24h and ECH < 1mg/24h; sterilant residual limits of EO < 4mg/24h and ECH < 9mg/24h; Sterility Assurance Level, SAL 10-6).

2.5 Physical Description

The schematic diagram below illustrates the range of dimensions for the new 7/8F models.

Image /page/4/Figure/9 description: This image shows a technical drawing of a medical instrument. The drawing includes labels for different parts of the instrument, such as the Luer Hub, Valve, Stopcock, Sheath, Dilator, and Marker Band. The drawing also includes measurements, such as 450-900mm, 515-965mm, and 300 mm, as well as 7Fr/8Fr.

{5}------------------------------------------------

French SizeLength (cm)ShapeCatalogue Number
7F45Crossover452386
7F45Straight452382
7F65Straight452383
7F90Straight452388
8F45Crossover452387
8F45Straight452385
8F65Straight452384
8F90Straight452389

2.6 Device Models

2.7 Materials Used

The materials that make up the device are either the same or very similar to those used for the predicate. Any differences in the material do not raise any new issues of safety or effectiveness, as demonstrated by the design verification test results.

2.8 Indications for Use

The Fortress Introducer Sheath System is intended to provide access and to facilitate percutaneous introduction of guide wires, catheters and other devices into the femoral, popliteal and infrapopliteal arteries while maintaining hemostasis during diagnostic and interventional procedures.

This is the same intended use as for the previously cleared 6F Fortress Introducer Sheath System (K153197).

2.9 Comparison of Technological Characteristics with the Predicate Device

The 7F and the 8F size of the Fortress Introducer Sheath System is a manually operated, sterile, single patient use sheath system made predominantly of thermoplastic polymers. The sheath is reinforced with a stainless steel coil in order to provide kink resistance when passed through tortuous paths. With regard to the design, device features, method of sterilization, and mode of operation, the 7F and 8F Fortress Introducer Sheath System does not differ from the predicate device.

Materials used for manufacture of the 7F and 8F Fortress Introducer Sheath System are the same or very similar as those contained in the predicate device. The slight differences in technological characteristics between the subject device and the predicate do not raise any new concerns of safety and effectiveness, as demonstrated by the data collected.

{6}------------------------------------------------

2.10 Performance Data

Performance data demonstrate that the Fortress Introducer Sheath System 7F and 8F performance is substantially equivalent to the predicate. The following performance data from non-clinical tests are being provided in support of the substantial equivalence determination:

  • Mechanical testing, including tests required under relevant international standards, and usability test performed to verify and validate the design.
  • . Biocompatibility Risk Assessment (BRA) and performed biocompatibility device testing to demonstrate biocompatibility.
  • . Sterilization information to confirm sterility of the device upon exposure to the selected sterilization cycle.
  • . Accelerated aging testing to confirm product performance at the end of the shelf life.

The list of tests performed in support of determination of substantial equivalence is provided in the table below.

No.Verification / Validation ActivityTest TypeApplicable Standard(s)
1Sheath/dilator fit testMechanical/VisualInternal requirement
2Sheath pull out testMechanical/VisualASTM F2394ISO 10555-1:2013
3Sheath kink resistance testMechanicalEN 13868:2002
4Sheath force at break testMechanicalISO 10555-1:2013
5Sheath creep to break testMechanicalISO 10555-1:2013
6Dilator hub bond strengthMechanicalISO 10555-1:2013
7Sheath system insertion forceMechanicalInternal requirement
8Usability evaluationUsability StudyIEC 62366-1:2015
9Simulated use testMechanical/VisualASTM F2394
10Accelerated age test(3 years)Mechanical/ ExternalLaboratoryASTM F1980-16Various per performed tests
11Biocompatibility testingCytotoxicity testBiological Risk AssessmentExternal LaboratoryDocumented assessmentISO 10993-1:2009ISO 10993-4:2017ISO 10993-5:2009ISO 10993-10:2010ISO 10993-11:2017ISO 10993-12:2012

List of Tests

{7}------------------------------------------------

No.Verification / Validation ActivityTest TypeApplicable Standard(s)
ISO 14971:2019FDA Guidance Use ofInternational Standard ISO10993-1
12Sterilization adoptionDocumented assessment/External laboratory testingISO 10993-7:2008ISO 11737-1:2018ISO 11135:2014ISO 10993-1:2018

2.11 Conclusions

The results of performed testing based on risk analysis demonstrate that the 7F and 8F Fortress Introducer Sheath System performs comparably with the predicate. The 7F and 8F Fortress Introducer Sheath System is substantially equivalent to the predicate device in terms of intended use, design and materials, technological characteristics, and principle of operation. Any differences between the subject device and the predicate do not raise any new issues of safety or effectiveness.

§ 870.1340 Catheter introducer.

(a)
Identification. A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.(b)
Classification. Class II (performance standards).